✦ LIBER ✦

Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo-controlled, double-blind study

✍ Scribed by G Kircheis; R Nilius; C Held; H Berndt; M Buchner; R Gortelmeyer; R Hendricks; B Kruger; B Kuklinski; H Meister; H Otto; C Rink; W Rosch; S Stauch

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 615 KB
Volume: 25
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510250609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Désirée van der Heijde; Alan Kivitz; Michael H. Schiff; Joachim Sieper; Ben A. C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Final results of a double-blind, placebo

Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-γ1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis

✍ Paul J. Pockros; Lennox Jeffers; Nezam Afdhal; Zachary D. Goodman; David Nelson; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB 👁 2 views

## Interferon-␥1b (IFN-␥1b ) is a pleiotropic cytokine that displays antifibrotic, antiviral, and antiproliferative activity. A total of 502 patients with compensated liver disease and an Ishak fibrosis score of 4-6 were randomized in a double-blind, placebo-controlled study, and 488 of these pati

Efficacy and safety of golimumab in pati

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

✍ Robert D. Inman; John C. Davis Jr.; Désirée Van Der Heijde; Laura Diekman; Joach 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## Abstract ## Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing spondylitis (AS) in the GO‐RAISE study. ## Methods Patients with active AS, a Bath AS Disease Activity Index (BASDAI) score ≥4, and a back pain score of ≥4 were randomly assigned in a 1.8:1.8:1

Efficacy and safety of milnacipran 100 m

Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: Results of a randomized, double-blind, placebo-controlled trial

✍ Lesley M. Arnold; R. Michael Gendreau; Robert H. Palmer; Judy F. Gendreau; Yong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 2 views

S-Adenosyl-L-methionine in the treatment

S-Adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: A randomized, double-blind, placebo-controlled study with negative results

✍ Dr. Jose Ribalta; Humberto Reyes; Manuel C. Gonzalez; Joaquin Iglesias; Marco Ar 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB

S-Adenosyl-L-methionine has been reported to induce beneficial effects in intrahepatic cholestasis of pregnancy. Because cholestasis of pregnancy has a high prevalence in Chile and a deleterious effect on fetal prognosis, we decided to verify the efficacy of S-adenosyl-L-methionine in this disease.

A multicentre double-blind placebo-contr

A multicentre double-blind placebo-controlled study investigating the anxiolytic efficacy of hydroxyzine in patients with generalized anxiety

✍ T. Darcis; M. Ferreri; J. Natens; B. Burtin; P. Deram 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

The efficacy of hydroxyzine was investigated in 110 patients suffering from generalized anxiety, in a double-blind placebo controlled multicentre study. Oral hydroxyzine 50mg/day for four weeks significantly improved standard measurements of anxiety compared with placebo control. These improvements